Suppression of PTPN6 may have deleterious effects at the molecular, cellular and tissue levels, leading to initiation of inflammation and apoptosis, ultimately resulting in the development of COPD-like lesions. The gene discussed is PTPN6; the disease is chronic obstructive pulmonary disease.